Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
2.72
0.02 (0.74%)
At close: Oct 03, 2025, 3:59 PM
2.71
-0.37%
After-hours: Oct 03, 2025, 04:37 PM EDT
Chemomab Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.65 | -7.48 | -11.52 | -7.9 | -3.8 | -2.83 | -1.92 | -2.6 | -1.84 | -2.01 | -4.5 | -3.42 | -6.82 | -10.73 | -15.62 | -42.55 | -74.25 | -132.05 |
PEG Ratio | -0.00 | 0.84 | 0.55 | 0.38 | 0.44 | -0.75 | 0.08 | 0.05 | 0.19 | -0.19 | -2.1 | -0.11 | -0.32 | 47.41 | -0.23 | -24.31 | -3.8 | 1.62 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.55 | 9.57 | 10.09 | 6.75 | 5.53 | 3.28 | 1.56 | 2.35 | 2.66 | 2.51 | 4.11 | 2.55 | 3.26 | 3.83 | 5.12 | 7.71 | 12.09 | 16.32 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -6.8 | -8.25 | -7.82 | -9.78 | -26.1 | -21.51 | -29.56 | -58.78 | -103.92 | -195.78 | -144.1 | -694.5 |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -6.8 | -8.25 | -7.82 | -9.78 | -26.11 | -21.68 | -29.62 | -59 | -108.73 | -195.79 | -146.72 | -696.11 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 7.42 | 5.33 | 4.98 | 4.57 | 3.12 | 3.83 | 4.32 | 4.17 | 4.05 | 6.68 | 6.18 | 15.83 | 22.71 | 29.81 | 24.16 | 57.63 | 42.74 | 12.85 |
Current Ratio | 7.42 | 5.33 | 4.98 | 4.57 | 3.12 | 3.83 | 4.32 | 4.16 | 4.06 | 4.83 | 6.18 | 8.90 | 12.48 | 16.87 | 23.66 | 40.39 | 31.88 | 12.85 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -2.03K | n/a | n/a | n/a | n/a | -320.07 | -35.09 | -13.18 | n/a | -416.76 | -37.37 | -161.35 | -343.36 |
Return on Equity | -0.21 | -0.32 | -0.22 | -0.21 | -0.36 | -0.29 | -0.2 | -0.23 | -0.36 | -0.31 | -0.23 | -0.19 | -0.12 | -0.09 | -0.08 | -0.05 | -0.04 | -0.03 |
Return on Assets | -0.18 | -0.26 | -0.17 | -0.17 | -0.25 | -0.21 | -0.16 | -0.17 | -0.28 | -0.25 | -0.19 | -0.17 | -0.11 | -0.08 | -0.08 | -0.04 | -0.04 | -0.03 |
Return on Invested Capital | -0.23 | -0.33 | -0.23 | -0.22 | -0.36 | -0.29 | -0.22 | -0.24 | -0.37 | -0.32 | -0.24 | -0.19 | -0.11 | -0.09 | -0.08 | -0.04 | -0.04 | -0.03 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |